Free tool
Stocks listed on Nasdaq GS
We cover 29 companies listed on Nasdaq GS. The median market value in the group is $2.97B. Across the group, the median move over the past trading day is −0.43%. 100% of the 29 with a 200-day average trade above it. Price change over the past year runs from −1.3% to +305.4% across the middle 80 percent of the group, with a median of +96.3%.
Other lists in this group
Table
29 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% | Nov 5, 2026 |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% | Oct 29, 2026 |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% | Nov 2, 2026 |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% | Nov 3, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% | Nov 5, 2026 |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% | Nov 5, 2026 |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% | Nov 4, 2026 |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% | Nov 11, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% | Nov 5, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% | Nov 9, 2026 |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% | Nov 5, 2026 |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% | Nov 5, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% | Nov 5, 2026 |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% | Nov 5, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% | Nov 13, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% | Nov 17, 2026 |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% | Nov 3, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% | Nov 11, 2026 |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% | Nov 4, 2026 |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% | Nov 5, 2026 |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% | Nov 5, 2026 |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% | Nov 3, 2026 |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% | Nov 3, 2026 |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% | Nov 11, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% | Nov 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.